Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

Tubular aggregates in congenital myasthenic syndrome.

Feresiadou A, Casar-Borota O, Dragomir A, Oldfors CH, Stålberg E, Oldfors A.

Neuromuscul Disord. 2017 Nov 24. pii: S0960-8966(17)30379-6. doi: 10.1016/j.nmd.2017.11.009. [Epub ahead of print] No abstract available.

PMID:
29311015
2.

Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.

Dragomir A, Aprikian A, Kapoor A, Finelli A, Pouliot F, Rendon R, Black PC, Moore R, Breau RH, Kawakami J, Drachenberg D, Lattouf JB, Tanguay S.

CMAJ Open. 2017 Dec 11;5(4):E834-E841. doi: 10.9778/cmajo.20170005.

3.

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients.

Niinivirta M, Enblad G, Edqvist PH, Pontén F, Dragomir A, Ullenhag GJ.

J Cancer. 2017 Oct 23;8(19):3975-3983. doi: 10.7150/jca.20889. eCollection 2017.

4.

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer.

Mezheyeuski A, Strell C, Hrynchyk I, Guren TK, Dragomir A, Doroshenko T, Pashkova O, Gorgun J, Ruksha K, Pfeiffer P, Kure EH, Sorbye H, Edler D, Martling A, Glimelius B, Östman A, Portyanko A.

Virchows Arch. 2017 Nov 13. doi: 10.1007/s00428-017-2263-3. [Epub ahead of print]

PMID:
29134439
5.

Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.

Bramhecha YM, Guérard KP, Rouzbeh S, Scarlata E, Brimo F, Chevalier S, Hamel L, Dragomir A, Aprikian AG, Lapointe J.

Mol Cancer Res. 2018 Jan;16(1):115-123. doi: 10.1158/1541-7786.MCR-17-0270. Epub 2017 Oct 9.

PMID:
28993510
6.

Comparison of Surgery and Radiation as Local Treatments in the Risk of Locoregional Complications in Men Subsequently Dying From Prostate Cancer.

Hu J, Aprikian AG, Cury FL, Vanhuyse M, Zakaria AS, Richard PO, Perreault S, Dragomir A.

Clin Genitourin Cancer. 2017 Sep 5. pii: S1558-7673(17)30266-5. doi: 10.1016/j.clgc.2017.08.011. [Epub ahead of print]

PMID:
28943330
7.

Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice.

Cedervall J, Dragomir A, Saupe F, Zhang Y, Ärnlöv J, Larsson E, Dimberg A, Larsson A, Olsson AK.

Oncoimmunology. 2017 Apr 20;6(8):e1320009. doi: 10.1080/2162402X.2017.1320009. eCollection 2017.

PMID:
28919990
8.

Identification of Mutations in SDR9C7 in 6 Families with Autosomal Recessive Congenital Ichthyosis.

Hotz A, Fagerberg C, Vahlquist A, Bygum A, Törmä H, Rauschendorf MA, Zhang H, Heinz L, Bourrat E, Hausser I, Vestergaard V, Dragomir A, Zimmer AD, Fischer J.

Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15994. [Epub ahead of print]

PMID:
28906551
9.

Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study.

Dragomir A, Rocha J, Vanhuyse M, Cury FL, Kassouf W, Hu J, Aprikian AG.

Curr Oncol. 2017 Aug;24(4):240-248. doi: 10.3747/co.24.3598. Epub 2017 Aug 31.

10.

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.

Siesing C, Sorbye H, Dragomir A, Pfeiffer P, Qvortrup C, Pontén F, Jirström K, Glimelius B, Eberhard J.

PLoS One. 2017 Aug 11;12(8):e0182512. doi: 10.1371/journal.pone.0182512. eCollection 2017.

11.

Carrier frequency modulation of an acousto-optic modulator for laser stabilization.

Aldous M, Woods J, Dragomir A, Roy R, Himsworth M.

Opt Express. 2017 May 29;25(11):12830-12838. doi: 10.1364/OE.25.012830.

PMID:
28786635
12.

Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.

Klaassen Z, Li K, Kassouf W, Black PC, Dragomir A, Kulkarni GS.

Can Urol Assoc J. 2017 Jun;11(6):173-181. doi: 10.5489/cuaj.4568.

13.

Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada.

Zakaria AS, Santos F, Dragomir A, Kassouf W, Tanguay S, Aprikian A.

Urol Oncol. 2017 Sep;35(9):539.e1-539.e7. doi: 10.1016/j.urolonc.2017.04.005. Epub 2017 May 4.

PMID:
28479117
14.

Impact of abiraterone acetate with and without prior docetaxel chemotherapy on the survival of patients with metastatic castration-resistant prostate cancer: a population-based study.

Rocha J, Aprikian AG, Vanhuyse M, Cury FL, Hu J, Prévost N, Dragomir A.

CMAJ Open. 2017 Mar 28;5(1):E265-E272. doi: 10.9778/cmajo.20160082. eCollection 2017 Jan-Mar.

15.

Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib.

Niinivirta M, Enblad G, Edqvist PH, Pontén F, Dragomir A, Ullenhag GJ.

J Cancer Res Clin Oncol. 2017 Jun;143(6):961-970. doi: 10.1007/s00432-017-2365-y. Epub 2017 Mar 4.

16.

Asporin is a stromally expressed marker associated with prostate cancer progression.

Rochette A, Boufaied N, Scarlata E, Hamel L, Brimo F, Whitaker HC, Ramos-Montoya A, Neal DE, Dragomir A, Aprikian A, Chevalier S, Thomson AA.

Br J Cancer. 2017 Mar 14;116(6):775-784. doi: 10.1038/bjc.2017.15. Epub 2017 Feb 2.

17.

Ventral Tegmental Area Dopamine Neurons Firing Model Reveals Prenatal Nicotine Induced Alterations.

Dragomir A, Akay YM, Zhang D, Akay M.

IEEE Trans Neural Syst Rehabil Eng. 2017 Sep;25(9):1387-1396. doi: 10.1109/TNSRE.2016.2636133. Epub 2016 Dec 6.

PMID:
28114025
18.

[Social cognition disorders in Klinefelter syndrome: A specific phenotype? (KS)].

Babinet MN, Rigard C, Peyroux É, Dragomir AR, Plotton I, Lejeune H, Demily C.

Encephale. 2017 Oct;43(5):423-428. doi: 10.1016/j.encep.2016.04.010. Epub 2016 Oct 13. French.

PMID:
27743676
19.

Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure.

Kanlikilicer P, Zhang D, Dragomir A, Akay YM, Akay M.

Med Biol Eng Comput. 2017 Mar;55(3):467-482. doi: 10.1007/s11517-016-1531-8. Epub 2016 Jun 2.

PMID:
27255453
20.

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer.

Mezheyeuski A, Bradic Lindh M, Guren TK, Dragomir A, Pfeiffer P, Kure EH, Ikdahl T, Skovlund E, Corvigno S, Strell C, Pietras K, Ponten F, Mulder J, Qvortrup C, Portyanko A, Tveit KM, Glimelius B, Sorbye H, Östman A.

Oncotarget. 2016 Jul 5;7(27):41948-41958. doi: 10.18632/oncotarget.9632.

Supplemental Content

Loading ...
Support Center